AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

SRTA · NASDAQ · Medical - Care Facilities

Strata Critical Medical (SRTA)

Coordinates organ-transport logistics and surgical recovery services for U.S. transplant centers.

$5.47

vs last close+0.07 (+1.20%)

In millions of USD, except per-share figures

In millions	Q3 FY23Sep 2023	Q4 FY23Dec 2023	Q1 FY24Mar 2024	Q2 FY24Jun 2024	Q3 FY24Sep 2024	Q4 FY24Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25Dec 2025	Q1 FY26Mar 2026	Q2 FY26Jun 2026
Revenue	71	47	52	68	75	54	54	71	49	67	67	73
Cost of revenue	56	38	41	52	55	42	42	53	38	55	53	57
Gross profit	16	9	10	16	20	13	12	18	12	12	14	15
	23	45	20	29	23	21	20	23	17	18	17	21
Research & development	1	1	1	1	1	1	1	1	0	0	0	0
	22	44	19	28	23	20	19	22	17	17	16	9
Selling & marketing	3	2	2	2	2	1	1	2	0	0	0	0
General & administrative	19	41	17	25	20	19	17	20	16	0	0	9
Other expenses	0	0	0	0	0	0	0	0	0	1	1	11
Operating income	−7	−36	−10	−12	−4	−8	−8	−5	−6	−6	−3	−5
	8	1	6	1	1	−2	4	1	−4	1	5	−5
Interest income	2	2	2	2	2	2	1	1	1	1	0	0
Other non-operating income	0	−1	−6	−1	−1	2	−4	−1	4	−3	−1	5
Income before tax	0	−35	−4	−11	−2	−10	−4	−4	−10	−5	2	−11
Income tax expense	0	−1	0	0	0	0	0	0	0	0	0	0
Net income from continuing operations	0	−34	−4	−11	−2	−10	−3	−4	−10	−5	2	−11
Discontinued operations	0	0	0	0	0	0	0	0	67	−3	0	0
Net income	0	−34	−4	−11	−2	−10	−3	−4	57	−9	2	−11
EPS, basic	$0.00	−$0.45	−$0.06	−$0.15	−$0.03	−$0.12	−$0.04	−$0.05	$0.70	−$0.11	$0.03	−$0.12
EPS, diluted	$0.00	−$0.45	−$0.06	−$0.15	−$0.03	−$0.12	−$0.04	−$0.05	$0.70	−$0.11	$0.03	−$0.12
Weighted average shares, basic	74	75	76	78	78	79	80	81	82	82	85	86
Weighted average shares, diluted	81	75	76	78	78	79	80	81	82	82	90	86
EBITDA	−6	−33	−3	−10	−1	−8	−2	−2	−8	−1	1	−2
Depreciation & amortization	2	2	2	2	1	2	2	2	2	3	3	9
EBIT	−7	−35	−4	−11	−2	−10	−4	−4	−10	−4	−2	−11